Skip to Main Content

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

To demonstrate the proof of principle and initial clinical safety of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve) and increase the efficiency of the device development process by identifying appropriate modifications to the implant procedure or the device.

  • Ages
    1 year - 70 years
  • Gender
    Both
Find out more about who can participate in this trial
  • Trial with
    CorMatrix Cardiovascular, Inc.
  • Start Date
    02/04/2021
  • End Date
    12/31/2020

For more information about this study, contact:

Rodolfo Molina

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Sub-Investigators

  • Last Updated
    04/08/2022
  • Study HIC
    #2000028726

Contact Information

For more information about this study, including how to volunteer, contact Rodolfo Molina

Volunteer Now